Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy: Table 1

Loverro, Giuseppe; Naro, Edoardo Di; Caringella, Anna Maria; Robertis, Anna Lisa De; Loconsole, Daniela; Chironna, Maria

doi:10.1136/sextrans-2014-051987

Cited by 33 publications

(31 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a recent study, Loverro et al 10 reported on HPV prevalence in transgendered persons in Italy, in which one out of a total of eight women who underwent vaginoplasty tested positive for vaginal hrHPV. However, the number of included patients in this study is small, so the true clinical importance and burden of neovaginal HPV infections in transgender women in Europe remains unclear.…”

Section: Discussionmentioning

confidence: 99%

Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature

et al. 2016

View full text Add to dashboard Cite

show abstract

“…The fifth case, with skin graft, was not tested for HPV; however, the immunostain for p16 turned out to be negative [4][5][6][7]. Transgender women have a high prevalence of sexually transmitted infections, with a HPV infection rate of 52.4%, all of which have at least one high-risk genotype [10][11][12][13][14]. This could be explained by several contributory factors.…”

Section: Discussionmentioning

confidence: 99%

HPV-Related Neovaginal Squamous Cell Carcinoma Presenting as Lung Metastasis after Male-to-Female Gender Confirmation Surgery

et al. 2020

View full text Add to dashboard Cite

There have been 4 reported cases of squamous cell carcinoma (SCC) of the neovagina in transgender women. In this report, we present another case of neovaginal SCC in a transgender woman, which was HPV-related, with lung metastasis as the initial presentation, and which was also complicated by her previous history of metastatic renal cell carcinoma. This unique case highlights the diagnostic challenges in these unusual scenarios. Through this report, we hope to address the benefits of multidisciplinary tumor board rounds, provision of detailed clinical information, and familiarization of the transgender anatomy within the pelvis in this group of patients. We also propose that transgender women undergo a continuous annual follow-up after postoperative follow-up is completed. mation surgery, vaginoplasty is usually done by penile and scrotal skin inversion [3]. There have been 4 cases of SCC of the neovagina in transgender women reported, all presented as neovaginal discharge or bleeding [4][5][6][7]. In this report, we present another case of neovaginal SCC in a transgender woman, with lung metastasis as the initial presentation. This case had also been further complicated by her previous history of metastatic renal cell carcinoma.

show abstract

“…34 Several small studies have determined the HPV burden in the transgender community to range from 40% to 95%, with the majority of the identified strains high risk for oncogenic potential. 31,[35][36][37] Furthermore, only 27% of transgender men responding to the 2015 U.S. Transgender Survey had a Pap smear in the past year, compared with 43% in the U.S. adult population, increasing the risk for undetected and persistent HPV. 38 The 2015 U.S. Transgender Survey identified that specifically among transgender men, only 14% had undergone hysterectomy and an additional 44% responded that they desired a hysterectomy in the future.…”

Section: Cervical Cancermentioning

confidence: 99%

Care and Cancer Screening of the Transgender Population

Puechl

Russell

Gray

2019

Journal of Women's Health

View full text Add to dashboard Cite

As sex and gender are assigned at birth before gender identity development, many individuals experience feelings of discordance between their gender identity and their sex and gender assigned at birth. The transgender community has not been well understood by medical and mental health fields. As such, this marginalized and vulnerable community faces multiple barriers to receiving health maintenance and specialized care, both at the community and patient-specific level. Many transgender individuals undergo some form of transition to the gender that matches their gender identity. Transition efforts look different for each patient because gender and gender identity occur along a continuum. Transition may include social, hormonal, and/or surgical components. As providers are caring for transgender patients, it is imperative to understand where a patient is in their gender transition and how hormonal and/or surgical therapies affect their cancer risk and screening. The aim of this article is to describe appropriate cancer screening practices and important care considerations for the primary care physician and generalist gynecologist taking care of transgender individuals.

show abstract

Prevalence of human papillomavirus infection in a clinic sample of transsexuals in Italy: Table 1

Abstract: The high rate of detectable HPV DNA by oncogenic types suggests that periodic cytological screening and clinical evaluation may be necessary since transsexuals are at high risk of anogenital cancer. Also promoting HPV vaccination in younger subjects may be advisable.

Cited by 33 publications

References 8 publications

Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature

Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature

HPV-Related Neovaginal Squamous Cell Carcinoma Presenting as Lung Metastasis after Male-to-Female Gender Confirmation Surgery

Care and Cancer Screening of the Transgender Population

Contact Info

Product

Resources

About